Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like nothing new at conference. Need to wait for real result sto move stock.
8-K filed today.
On July 20, 2017, Weyland Tech, Inc. (the “Company”) entered into an advisory agreement with TMC Prime Pte. Ltd (TMC) for the sourcing of strategic investments into the company by Southeast Asian technology companies and high net worth individuals with experience investing in technology companies TMC will commit to fund up to $10 million USD over a period of one year via direct investments.
The principals of TMC are former founders and executives of regionally based systems integrators, cloud services and mobile telephony companies.
I agree. Q2 will be up 20% with Q3 and Q4 hitting it out of the park!
According to IR, they are making money on the beta!
Nice find!!!
Short term, this thing is a POS. They won the court case and didn't put out a PR. Where are the 1 million shares in public float???
April was orders; not shipments. But don't worry, it will come in Q3 and Q4 big time!
Q2 should be 20% growth with Q3 and Q4 100% growth based upon backlog.
I agree. The Terpenez should provide nice growing recurring revenue stream!
I didn't get an answer when I asked IR about when they go from beta to live in the telecom provider project. Any one have any ideas? Seems to be taking a lot longer than originally believed.
Q3 and Q4 will be way better than Q2.
Combo drug reduces blood pressure side effect of regular Celebrex. Don't know about renal effects yet but if that is reduced or not, doctors will prescribe it and health plans with cover it because of better compliance. Of course, depends on pricing as well.
Bid price is the dip here!
Added to Russell Microcap this month (23rd)
Nice find. Thanks. Appears to be breaking out of wedge this morning.
Meant to say wedge
Possible hedge in the works....
http://stockcharts.com/h-sc/ui?s=SLTK&p=D&yr=0&mn=6&dy=0&id=p86610417710&listNum=1&a=519372751
Double bottom. 5/31 and today. Both closed way off lows.
IR has said that secondary after uplist is not planned.
That's true from everything I've heard.
Expecting 100%+ revenue growth YoY in both Q2 and Q3.
ZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
like watching paint dry.....
Is it Alan Brochstein?
I am wondering if it is the firm from which the analyst is writing a recommendation is trying to get their clients in before the report comes out!
Now waiting on announcement of additional strategic partners (telecom provider, etc). Any ideas on when? Supposedly WEYL work is done and they are waiting partner/user testing.
Their facebook page.
Terpenez is a nutrient developed by Solis Tek. It is currently available from their hydroponic store retailer growsolutions.com and through distributors.
The product is manufactured/blended the our Carson, CA facility under a proprietary formula.
They have not announced this via PR yet. Think recurring revenue stream!
Expecting better than expected results for Q1 next week. Definitely better than the Zack's analyst expectations.
Think of WEYL as a mini-SHOPify. WEYL just specializes in the Asian market with all emphasis on mobile apps. The valuation on SHOP is just crazy right now. Price to sales ratio over 17 and PE ratio -177. WEYL price to sales ratio a little over 6.
Highest daily volume yet! No news to account for it. Potential analyst coverage soon though.
Would not be surprised to see the 800K short seller buy a $3M private placement from the company to cover it's illegal short! But it would be more fun and better for current shareholders to see them cover in the open market.